A

Alivus Life Sciences Ltd

PharmaceuticalsSmallcap

About the company

Alivus Life Sciences Ltd develops and manufactures active pharmaceutical ingredients (APIs) and provides contract development and manufacturing services for chronic therapeutic areas.

Performance

Stock
Loading Stock value

Analyst Ratings and Key Metrics

Based on 3 analysts offering recommendations for Alivus Life Sciences Ltd

100%

Buy

0%

Hold

0%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio23.8835.98
PB Ratio4.125.67
Dividend Yield0.53%0.59%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions